6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04956939 (ClinicalTrials.gov) | July 17, 2018 | 11/6/2021 | Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease | Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease | Parkinson Disease | Drug: Low dose levodopa;Drug: High dose levodopa | Rush University Medical Center | NULL | Completed | 40 Years | 80 Years | All | 38 | United States |